George A. Calin

1.7k total citations
31 papers, 685 citations indexed

About

George A. Calin is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, George A. Calin has authored 31 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in George A. Calin's work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). George A. Calin is often cited by papers focused on MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). George A. Calin collaborates with scholars based in United States, Italy and Romania. George A. Calin's co-authors include Mihnea P. Dragomir, Erik Knutsen, Mihir K. Bhayani, Stephen Y. Lai, Barbara Pardini, Carlo M. Croce, Arianna Bottoni, Maria Ciccone, Stefano Volinia and Laura Paladini and has published in prestigious journals such as Cell, Blood and Cancer Cell.

In The Last Decade

George A. Calin

31 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George A. Calin United States 14 521 496 49 48 46 31 685
Wei‐Neng Fu China 17 565 1.1× 344 0.7× 52 1.1× 99 2.1× 29 0.6× 43 712
Akiko Yashima‐Abo Japan 8 296 0.6× 254 0.5× 28 0.6× 45 0.9× 45 1.0× 19 421
Anneleen Beckers Belgium 14 530 1.0× 296 0.6× 100 2.0× 65 1.4× 23 0.5× 20 777
Perry S. Mongroo United States 6 477 0.9× 308 0.6× 51 1.0× 106 2.2× 31 0.7× 6 642
Guoqi Song China 15 358 0.7× 257 0.5× 77 1.6× 75 1.6× 20 0.4× 30 523
Romina Sepe Italy 17 666 1.3× 381 0.8× 42 0.9× 134 2.8× 79 1.7× 26 835
Ciara Barrett Ireland 13 550 1.1× 457 0.9× 40 0.8× 92 1.9× 56 1.2× 21 738
Dongtao Fu United States 9 233 0.4× 159 0.3× 53 1.1× 96 2.0× 60 1.3× 16 407
Tian Liang China 12 354 0.7× 293 0.6× 56 1.1× 47 1.0× 55 1.2× 23 485

Countries citing papers authored by George A. Calin

Since Specialization
Citations

This map shows the geographic impact of George A. Calin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Calin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Calin more than expected).

Fields of papers citing papers by George A. Calin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Calin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Calin. The network helps show where George A. Calin may publish in the future.

Co-authorship network of co-authors of George A. Calin

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Calin. A scholar is included among the top collaborators of George A. Calin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Calin. George A. Calin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhiwei, Yan Lü, Kang Wang, et al.. (2024). Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(1). 103–121. 2 indexed citations
2.
Luca, Gabriele De, Laura Chronopoulou, Francesca Pedini, et al.. (2023). MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance. Molecular Therapy. 32(1). 152–167. 9 indexed citations
3.
Terracciano, Daniela, Carlo Buonerba, Luca Scafuri, et al.. (2020). Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Frontiers in Oncology. 10. 2 indexed citations
4.
Dragomir, Mihnea P., Erik Knutsen, & George A. Calin. (2018). SnapShot: Unconventional miRNA Functions. Cell. 174(4). 1038–1038.e1. 160 indexed citations
5.
D’Abundo, Lucilla, Elisa Callegari, Antonella Bresin, et al.. (2017). Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. Oncogene. 36(47). 6617–6626. 18 indexed citations
6.
Rozovski, Uri, Inbal Hazan‐Halevy, George A. Calin, et al.. (2016). Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome. Journal of Visualized Experiments. 1 indexed citations
7.
Ciccone, Maria & George A. Calin. (2016). MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights. MicroRNA. 5(2). 106–112. 2 indexed citations
8.
Lupini, Laura, Felice Pepe, Manuela Ferracin, et al.. (2016). Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 7(21). 31361–31371. 46 indexed citations
9.
Ciccone, Maria & George A. Calin. (2015). MicroRNAs in Myeloid Hematological Malignancies. Current Genomics. 16(5). 336–348. 9 indexed citations
10.
Calin, George A., et al.. (2015). The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Medical Genetics. 16(1). 46–46. 11 indexed citations
11.
Ruvolo, Peter P., Vivian Ruvolo, Rodrigo Jácamo, et al.. (2014). The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(9). 1969–1977. 30 indexed citations
12.
Bottoni, Arianna & George A. Calin. (2014). MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia. MicroRNA. 2(3). 158–164. 16 indexed citations
13.
Ciccone, Maria, Alessandra Ferrajoli, Michael J. Keating, & George A. Calin. (2014). SnapShot: Chronic Lymphocytic Leukemia. Cancer Cell. 26(5). 770–770.e1. 7 indexed citations
14.
Galasso, Marco, Paola Dama, Maurizio Previati, et al.. (2014). A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6(10). 76–76. 30 indexed citations
15.
Armenia, Joshua, Linda Fabris, Francesca Lovat, et al.. (2014). Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget. 5(5). 1185–1197. 14 indexed citations
16.
Santarpia, Libero, George A. Calin, Liana Adam, et al.. (2013). A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocrine Related Cancer. 20(6). 809–823. 75 indexed citations
17.
Rozovski, Uri, George A. Calin, David Harris, et al.. (2013). Signal Transducer and Activator of Transcription (STAT)-3-Dependent Regulation of Non-Coding RNA in Small lymphocytic lymphoma/Chronic lymphocytic leukemia (CLL). Clinical Lymphoma Myeloma & Leukemia. 13. S363–S363. 1 indexed citations
18.
Hudson, Robert, Ming Yi, Natalia Volfovsky, et al.. (2013). Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Molecular Cancer. 12(1). 13–13. 51 indexed citations
19.
Bhayani, Mihir K., George A. Calin, & Stephen Y. Lai. (2011). Functional relevance of miRNA* sequences in human disease. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 731(1-2). 14–19. 68 indexed citations
20.
Zanesi, Nicola, Yuri Pekarsky, Francesco Trapasso, George A. Calin, & Carlo M. Croce. (2010). MicroRNAs in mouse models of lymphoid malignancies. PubMed. 1(1). 8–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026